Effects of isoflurane delayed preconditioning on nuclear factor-κB during myocardial ischemia reperfusion injury in rabbits

Chinese Journal of Emergency Medicine

Volumn 17, Issue 8, 2008, Pages 834-837

  Ran, Ke ^a   Duan, Kai Ming ^a   Zou, Ding Quan ^a   Zhu, Rong ^a   Ruan, Wen Yan ^a   Chang, Ye Tian ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Delayed preconditioning; Ischemia reperfusion injury; Isoflurane; Myocardial; NF B

Indexed keywords

EID: 50449088388     PISSN: 16710282     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Qian LP, Zhu SS, Cao JL, et al. Isoflurane preconditioning protects against ischemia-reperfusion injury partly by attenuating cytochrome c release from subsarcolemmal mitochondria in isolated rat hearts[J]. Acta Pharmacol Sin, 2005,26(7):813-820.
2. Tanaka K, Ludwig LM, Krolikowski JG, et al. Isoflurane produces delayed preconditioning against myocardial ischemia and reperfusion injury: role of cyclooxygenase-2[J]. Anesthesiology, 2004, 100(3):525-531.
3. Shi Y, Hutchins WC, Su J, et al. Delayed cardioprotection with isoflurane: role of reactive oxygen and nitrogen[J]. Am J Physiol Heart Circ Physiol, 2005, 288(1):175-184.
4. Tonkovic-Capin M, Gross GJ, Bosnjak ZJ, et al. Delayed cardioprotection by isoflurane: role of KATP channels[J]. Am J Physiol Heart Circ Physiol, 2002,283(1):61-68.
5. Valen G. Signal transduction through nuclear factor kappa B in ischemia-reperfusion and heart failure[J]. Basic Res Cardiol, 2004,99(1):1-7.
6. Frangogiannis NG, Smith CW, Entman ML. The inflammatory response in myocardial infaretion[J]. Cardiovasc Res, 2002,53(1):31-47.
7. Chinese source.
8. Liu X, Shen J, Jin Y, et al. Recombinant human erythropoietin (rhEP-O) preconditioning on nuclear factor-kappa B (NF-κB) activation & proinflammatory cytokines induced by myocardial ischaemia-reperfusion [J]. Indian J Med Res, 2006, 124(3):343-354.
9. Zaugg M, Lucchinetti E, Garcia C, et al. Anaesthetics and cardiac preconditioning II clinical implications [J]. Br J Anaesth, 2003,91(4): 566-576.
10. Sack MN, Smith RM, Opie LH. Tumor necrosis factor in myocardial hypertrophy and ischaemia-an anti-apoptotic perspective[J]. Cardiovasc Res, 2000,45(3):688-695.
11. Chinese source.
12. Frangogiannis NG, Mendoza LE, Lindsey ML, et al. IL-10 is induced in the reperfused myocardium and may modulate the reaction to injury[J]. J Immunol, 2000,165(5):2798-2808.
13. Yang Z, Zingarelli B, Szabo C. Crucial role of endogenous interleakin-10 production in myocardial ischemia/reperfusion injury[J]. Circulation, 2000,101(9):1019-1026.
14. Chinese source.
15. Chinese source.
16. Liu X, Xie W, Liu P, et al. Mechanism of the cardioprotection of rhE-PO pretreatment on suppressing the inflammatory response in ischemia-reperfusion [J]. Life Sci, 2006,78(19):2255-2264.
17. Yeh CH, Chen TP, Wu YC, et al. Inhibition of NF kappa B activation with curcumin attenuates plasma inflammatory cytokines surge and cardiomyocytic apoptosis following cardiac ischemia/reperfusion[J]. J Surg Res, 2005,125(1):109-116.